What is multidrug resistance TB?
The TB bacteria can become resistant to a drug or several drugs used to treat the disease. Drug resistance can occur when TB patients do not adhere to their prescribed drug regimens, health professionals prescribe an incorrect treatment regimen, or an unreliable drug supply interrupts patients’ treatment. This means that the drug can no longer kill the bacteria. Drug resistance is more common in people who have spent time with someone with drug-resistant TB disease; do not take their medicine regularly; do not take all of their prescribed medicine; develop TB disease after having taken TB medicine in the past; or come from areas where drug-resistant TB is common. Sometimes the bacteria become resistant to more than one drug. This is called multidrug-resistant TB, or MDR-TB. People with MDR-TB disease must be treated with specific drugs that often are much more expensive than conventional therapy.
Related Questions
- Could polymorphisms in ATP-binding cassette C3/multidrug resistance associated protein 3 (ABCC3/MRP3) modify colorectal cancer risk?
- Does the HIV/tuberculosis association favor the development of multidrug resistance TB (MDRTB) cases?
- Does verapamil help overcome multidrug resistance in tumor cell lines and cancer patients?
